Cargando…

Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE

Dystonia is the third most common movement disorder, but its diagnosis and treatment remain challenging. One of the most severe types of dystonia is early-onset torsion dystonia (EOTD). The best studied and validated EOTD-associated mutation, torsinAΔE, is a deletion of a C-terminal glutamate residu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zacchi, Lucía F., Dittmar, John C., Mihalevic, Michael J., Shewan, Annette M., Schulz, Benjamin L., Brodsky, Jeffrey L., Bernstein, Kara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611967/
https://www.ncbi.nlm.nih.gov/pubmed/28768697
http://dx.doi.org/10.1242/dmm.029926
_version_ 1783266036564361216
author Zacchi, Lucía F.
Dittmar, John C.
Mihalevic, Michael J.
Shewan, Annette M.
Schulz, Benjamin L.
Brodsky, Jeffrey L.
Bernstein, Kara A.
author_facet Zacchi, Lucía F.
Dittmar, John C.
Mihalevic, Michael J.
Shewan, Annette M.
Schulz, Benjamin L.
Brodsky, Jeffrey L.
Bernstein, Kara A.
author_sort Zacchi, Lucía F.
collection PubMed
description Dystonia is the third most common movement disorder, but its diagnosis and treatment remain challenging. One of the most severe types of dystonia is early-onset torsion dystonia (EOTD). The best studied and validated EOTD-associated mutation, torsinAΔE, is a deletion of a C-terminal glutamate residue in the AAA+ ATPase torsinA. TorsinA appears to be an endoplasmic reticulum (ER)/nuclear envelope chaperone with multiple roles in the secretory pathway and in determining subcellular architecture. Many functions are disabled in the torsinAΔE variant, and torsinAΔE is also less stable than wild-type torsinA and is a substrate for ER-associated degradation. Nevertheless, the molecular factors involved in the biogenesis and degradation of torsinA and torsinAΔE have not been fully explored. To identify conserved cellular factors that can alter torsinAΔE protein levels, we designed a new high-throughput, automated, genome-wide screen utilizing our validated Saccharomyces cerevisiae torsinA expression system. By analyzing the yeast non-essential gene deletion collection, we identified 365 deletion strains with altered torsinAΔE steady-state levels. One notable hit was EUG1, which encodes a member of the protein disulfide isomerase family (PDIs). PDIs reside in the ER and catalyze the formation of disulfide bonds, mediate protein quality control and aid in nascent protein folding. We validated the role of select human PDIs in torsinA biogenesis in mammalian cells and found that overexpression of PDIs reduced the levels of torsinA and torsinAΔE. Together, our data report the first genome-wide screen to identify cellular factors that alter expression levels of the EOTD-associated protein torsinAΔE. More generally, the identified hits help in dissecting the cellular machinery involved in folding and degrading a torsinA variant, and constitute potential therapeutic factors for EOTD. This screen can also be readily adapted to identify factors impacting the levels of any protein of interest, considerably expanding the applicability of yeast in both basic and applied research.
format Online
Article
Text
id pubmed-5611967
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-56119672017-09-29 Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE Zacchi, Lucía F. Dittmar, John C. Mihalevic, Michael J. Shewan, Annette M. Schulz, Benjamin L. Brodsky, Jeffrey L. Bernstein, Kara A. Dis Model Mech Resource Article Dystonia is the third most common movement disorder, but its diagnosis and treatment remain challenging. One of the most severe types of dystonia is early-onset torsion dystonia (EOTD). The best studied and validated EOTD-associated mutation, torsinAΔE, is a deletion of a C-terminal glutamate residue in the AAA+ ATPase torsinA. TorsinA appears to be an endoplasmic reticulum (ER)/nuclear envelope chaperone with multiple roles in the secretory pathway and in determining subcellular architecture. Many functions are disabled in the torsinAΔE variant, and torsinAΔE is also less stable than wild-type torsinA and is a substrate for ER-associated degradation. Nevertheless, the molecular factors involved in the biogenesis and degradation of torsinA and torsinAΔE have not been fully explored. To identify conserved cellular factors that can alter torsinAΔE protein levels, we designed a new high-throughput, automated, genome-wide screen utilizing our validated Saccharomyces cerevisiae torsinA expression system. By analyzing the yeast non-essential gene deletion collection, we identified 365 deletion strains with altered torsinAΔE steady-state levels. One notable hit was EUG1, which encodes a member of the protein disulfide isomerase family (PDIs). PDIs reside in the ER and catalyze the formation of disulfide bonds, mediate protein quality control and aid in nascent protein folding. We validated the role of select human PDIs in torsinA biogenesis in mammalian cells and found that overexpression of PDIs reduced the levels of torsinA and torsinAΔE. Together, our data report the first genome-wide screen to identify cellular factors that alter expression levels of the EOTD-associated protein torsinAΔE. More generally, the identified hits help in dissecting the cellular machinery involved in folding and degrading a torsinA variant, and constitute potential therapeutic factors for EOTD. This screen can also be readily adapted to identify factors impacting the levels of any protein of interest, considerably expanding the applicability of yeast in both basic and applied research. The Company of Biologists Ltd 2017-09-01 /pmc/articles/PMC5611967/ /pubmed/28768697 http://dx.doi.org/10.1242/dmm.029926 Text en © 2017. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Resource Article
Zacchi, Lucía F.
Dittmar, John C.
Mihalevic, Michael J.
Shewan, Annette M.
Schulz, Benjamin L.
Brodsky, Jeffrey L.
Bernstein, Kara A.
Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE
title Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE
title_full Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE
title_fullStr Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE
title_full_unstemmed Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE
title_short Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE
title_sort early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinaδe
topic Resource Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611967/
https://www.ncbi.nlm.nih.gov/pubmed/28768697
http://dx.doi.org/10.1242/dmm.029926
work_keys_str_mv AT zacchiluciaf earlyonsettorsiondystoniaanovelhighthroughputyeastgeneticscreenforfactorsmodifyingproteinlevelsoftorsinade
AT dittmarjohnc earlyonsettorsiondystoniaanovelhighthroughputyeastgeneticscreenforfactorsmodifyingproteinlevelsoftorsinade
AT mihalevicmichaelj earlyonsettorsiondystoniaanovelhighthroughputyeastgeneticscreenforfactorsmodifyingproteinlevelsoftorsinade
AT shewanannettem earlyonsettorsiondystoniaanovelhighthroughputyeastgeneticscreenforfactorsmodifyingproteinlevelsoftorsinade
AT schulzbenjaminl earlyonsettorsiondystoniaanovelhighthroughputyeastgeneticscreenforfactorsmodifyingproteinlevelsoftorsinade
AT brodskyjeffreyl earlyonsettorsiondystoniaanovelhighthroughputyeastgeneticscreenforfactorsmodifyingproteinlevelsoftorsinade
AT bernsteinkaraa earlyonsettorsiondystoniaanovelhighthroughputyeastgeneticscreenforfactorsmodifyingproteinlevelsoftorsinade